Callan Family Office’s Newmont NEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.99M Sell
32,059
-1,148
-3% -$125K 0.06% 294
2026
Q1
$3.59M Sell
33,207
-83
-0.2% -$9.57K 0.08% 245
2025
Q4
$3.32M Buy
33,290
+14,526
+77% +$1.31M 0.07% 250
2025
Q3
$1.58M Sell
18,764
-3,368
-15% -$235K 0.05% 299
2025
Q2
$1.29M Buy
22,132
+15,856
+253% +$846K 0.04% 350
2025
Q1
$303K Sell
6,276
-6,653
-51% -$292K 0.02% 425
2024
Q4
$481K Buy
+12,929
New +$589K 0.03% 377

Other funds holding NEM

Callan Family Office's NEM Position: Q2 2026 in Review

Callan Family Office reduced its Newmont (NEM) stake by 3.5% in Q2 2026, selling an estimated $125K and leaving 32,059 shares worth $2.99M. The position accounts for 0.06% of the portfolio, ranked #294.

Callan Family Office first reported a position in NEM in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.59M in Q1 2026. 1,788 funds tracked by Wall St. Rank hold NEM as of Q2 2026.

  • Callan Family Office held 32,059 shares of Newmont worth $2.99M as of Q2 2026.
  • Callan Family Office sold 1,148 Newmont shares in Q2 2026, an estimated $125K.
  • Newmont made up 0.06% of Callan Family Office's portfolio in Q2 2026, its #294 holding.
  • Callan Family Office first reported a position in Newmont in Q4 2024 and has held it in 7 quarters since.
  • Callan Family Office's Newmont position peaked at $3.59M in Q1 2026.
  • 1,788 funds tracked by Wall St. Rank held Newmont as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.